Trust Company
VRTX icon

Trust Company’s Vertex Pharmaceuticals VRTX Stock Holding History

Trust Company’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$19.9K Hold
38
– – ﹤0.01% 393
2026
Q2 		$18.9K Hold
38
– – ﹤0.01% 383
2026
Q1 		$17K Hold
38
– – ﹤0.01% 394
2025
Q4 		$17.2K Sell
38
-1
-3% -$431 ﹤0.01% 391
2025
Q3 		$15.3K Hold
39
– – ﹤0.01% 297
2025
Q2 		$17.4K Hold
39
– – ﹤0.01% 285
2025
Q1 		$18.9K Hold
39
– – ﹤0.01% 293
2024
Q4 		$15.7K Hold
39
– – ﹤0.01% 297
2024
Q3 		$18.1K Sell
39
-6
-13% -$2.88K ﹤0.01% 263
2024
Q2 		$21.1K Hold
45
– – ﹤0.01% 247
2024
Q1 		$18.8K Sell
45
-836
-95% -$353K ﹤0.01% 254
2023
Q4 		$358K Sell
881
-56
-6% -$20.7K 0.05% 99
2023
Q3 		$326K Sell
937
-419
-31% -$147K 0.05% 101
2023
Q2 		$477K Sell
1,356
-103
-7% -$34.7K 0.07% 86
2023
Q1 		$460K Buy
1,459
+70
+5% +$21K 0.07% 96
2022
Q4 		$401K Sell
1,389
-107
-7% -$32.6K 0.07% 106
2022
Q3 		$433K Sell
1,496
-392
-21% -$113K 0.09% 87
2022
Q2 		$532K Buy
+1,888
New +$505K 0.11% 81
2015
Q3 		– Sell
-150
Closed -$19K – 392
2015
Q2 		$19K Buy
+150
New +$18.9K 0.01% 254

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $77.1B AUM 11.99% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return

Trust Company's VRTX Position: Q3 2026 in Review

Trust Company held its Vertex Pharmaceuticals (VRTX) position steady in Q3 2026 at 38 shares worth $19.9K. The position accounts for ﹤0.01% of the portfolio, ranked #393.

Trust Company first reported a position in VRTX in Q2 2015 and has held it in 19 quarters since. The position peaked at $532K in Q2 2022. 1,356 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Trust Company held 38 shares of Vertex Pharmaceuticals worth $19.9K as of Q3 2026.
  • Trust Company left its Vertex Pharmaceuticals share count unchanged in Q3 2026.
  • Vertex Pharmaceuticals made up ﹤0.01% of Trust Company's portfolio in Q3 2026, its #393 holding.
  • Trust Company first reported a position in Vertex Pharmaceuticals in Q2 2015 and has held it in 19 quarters since.
  • Trust Company's Vertex Pharmaceuticals position peaked at $532K in Q2 2022.
  • 1,356 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Trust Company's 13F filing for Q3 2026, filed 9 Oct 2026.